Russell Investments Group, Ltd.

Position in EYPT — EyePoint, Inc.

CIK 1692234 Seattle, WA

Position in EYPT

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,573,984

+$650,662 QoQ

Shares Held

110,069

+53.7% QoQ

Ownership

0.128%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#73

of 188 holders

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 93% Shared 0% None 7%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. EYPT ranks #99 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,573,984	110,069	+53.7%	Shares	Defined	2026-08-06
2026-03-31	$923,322	71,631	+1100.3%	Shares	Defined	2026-05-08
2025-12-31	$109,035	5,968	+11.5%	Shares	Defined	2026-02-17
2025-09-30	$76,212	5,352	+365.8%	Shares	Defined	2025-11-13
2025-03-31	$6,227	1,149	+4687.5%	Shares	Other	2025-05-13
2024-09-30	$191	24	-97.8%	Shares	Defined	2024-11-13
2024-06-30	$9,282	1,067	+5235.0%	Shares	Defined	2024-08-08
2024-03-31	$413	20	-99.9%	Shares	Defined	2024-05-08
2022-09-30	$223,876	28,303	0.0%	Shares	Defined	2022-11-04
2022-06-30	$222,744	28,303	—	Shares	Defined	2022-07-29
No filing history on record for this holder in this stock.